Key findings of independent internal control review and continued suspension of trading
Filed with HKEX · Stock code 1406 · · 22 pages · English
On 6ix: 6ix.com/news/key-findings-of-independent-internal-control-review-and-continued-suspension-of-trading
C Clarity Medical Group 清晰醫療集團 CLARITY MEDICAL GROUP HOLDING LIMITED 清晰醫療集團控股有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1406) KEY FINDINGS OF INDEPENDENT INTERNAL CONTROL REVIEW AND CONTINUED SUSPENSION OF TRADING This announcement is made by Clarity Medical Group Holding Limited (the “Company”, together with its subsidiaries, the “Group”) pursuant to Rule 13.09(
Clarity Medical Group Holding Limited on 6ix
Earlier from Clarity Medical
- Clarity Medical Says Court Dismisses Originating Summons Issued By Plaintiff On Sept 19
- Clarity Medical Receives Originating Summons From Former Director
Later from Clarity Medical
- Annual results for the year ended 31 March 2025
- Annual results for the year ended 31 March 2026
- Interim results for the six months ended 30 September 2025
- Appointment of executive director
- Supplemental announcement in relation to the appointment of executive director
Follow Clarity Medical into a list and get an email when it puts out news.
Follow Clarity Medical